Navigation Links
AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
Date:5/5/2009

omplications and advancing recovery. Furthermore, the invasive nature of the IV delivery mode poses infection risk as well as predisposition to analgesic gaps due to infiltrated and dislodged IV catheters. Additionally, the complexity and programmability of IV PCA pumps introduce opportunities for medication errors, which in some instances may be fatal.

About ARX-01 Sufentanil NanoTab PCA System

ARX-01 is a novel drug/device combination product candidate designed for use in hospital settings to provide non-invasive patient-controlled analgesia and maximize patient satisfaction with post-operative pain management. The ARX-01 Sufentanil NanoTab PCA System avoids many of the limitations of IV PCA approaches by providing a non-invasive, pre-programmed, handheld PCA solution. The handheld component of ARX-01 allows for convenient patient self- administration of sufentanil NanoTabs sublingually for oral transmucosal absorption. Sufentanil is a high therapeutic index opioid approved for intravenous and epidural administration. Although the analgesic efficacy of sufentanil has been well established, its use has been limited due to its short IV plasma half-time. In the NanoTab oral transmucosal dosage form, sufentanil demonstrates a therapeutically appropriate pharmacokinetic profile for post-operative PCA usage and has the potential for improved patient tolerability over IV PCA morphine.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals is a privately held pharmaceutical company dedicated to the development and commercialization of new therapies for the treatment of pain and other conditions where there is an unmet need for improved safety and efficacy. The company applies its proprietary NanoTab dosage form and delivery technologies to enhance the safety, therapeutic benefit and commercial attractiveness of currently approved compounds. For additional informa
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
2. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
5. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
6. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
7. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
8. Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes
9. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
10. Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
11. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... -- CANTEL MEDICAL CORP. (NYSE: ... intends to pay, for the first time, a semiannual ... per share annually, on the Company,s common stock. The ... share of outstanding common stock, to be paid on ... close of business on January 15, 2010. Future declaration ...
(Date:12/17/2009)... Masimo (Nasdaq: MASI ), the inventor of ... pulse oximetry, today announced that new research findings, ... Journal of Perinatology, show that Masimo ... cava flow (SVC) in preterm, very-low-birth-weight infants--representing a ... of systemic blood flow.(1) ,, SVC flow, ...
(Date:12/17/2009)... Frost & Sullivan is proud ... Innovation Award in molecular diagnostics to Intelligent ... to providing innovative technologies for the advancement ... in 2004, IntelligentMDx has introduced a proprietary ... tests that are clinically impactful, competitively differentiated, ...
Breaking Medicine Technology:Cantel Medical Authorizes Semiannual Dividend 2New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants 2New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants 3New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants 4New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants 5Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 2Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 3Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 4Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 5New Compact and Folding Reading Glasses from VisAcuity com 3A Never Leave Home Without Them 47465 1New Compact and Folding Reading Glasses from VisAcuity com 3A Never Leave Home Without Them 47465 2Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 1Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 2Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 3Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 4PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 47459 1PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 47459 2
(Date:12/17/2009)... leading high-tech,healthcare group, Golden Meditech Company Limited ("Golden ... to announce today that the Group,s,associate company FunTalk ... Holdings Limited, made its debut on the NASDAQ ... offering. The shares of FunTalk started,trading on December ... As of today, Golden Meditech holds ...
(Date:12/17/2009)... from a recent Thomson Reuters study show that Chinese ... in 1998 to nearly 112,000 in 2008. , ... of the biomedical literature, has evaluated more than 530 ... only 27 Chinese-authored papers were selected in 2004, this ... to be even higher in 2009. , Jane Hunter, ...
(Date:12/17/2009)... hospital clients Rutherford Hospital Inc. (Rutherfordton, N.C.), a management ... management client since 1992, were recently recognized as top-ranked ... ... Brentwood, Tenn. (PRWEB) ... Rutherford Hospital Inc. (Rutherfordton, N.C.), a management client since ...
(Date:12/17/2009)... Studies Important ,for the R&D Informatics Industry, , ... ... Cambridge Healthtech Institute is pleased to announce the participation of ... R&D Informatics Systems conference to be held on February 3-5, ... CA. This meeting has been integrated in the Informatics Channel ...
(Date:12/17/2009)... -- Motionsoft, Inc. announced today that it has ... Data Security Standards (DSS) certification, making it one ... the health and wellness space that has been ... the result of a collaborative effort formed by ... MasterCard Worldwide, American Express, Discover Financial Services and ...
Breaking Medicine News(10 mins):Health News:Golden Meditech's Associate Company Debuted on NASDAQ 2Health News:China rapidly catching up in research impact 2Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Motionsoft Completes PCI Compliance Certification 2
... and Washington, D.C., WASHINGTON, Oct. 13 ... Coping With Deployments: Psychological First,Aid for Military Families, ... is open to military family members of active ... veterans and their families. Presently,the course is offered ...
... among Physicians, MOUNTAIN VIEW, Calif., Oct. 13 ... IT market, Frost & Sullivan recognizes,Infor-Med, Inc. with ... for,Technology Innovation for its novel Praxis(R) Electronic Medical ... Exchanger., The Praxis(R) EMR system employs a ...
... Energy Enhancing Supplement, BOCA RATON, Fla., Oct. 13 ... Go to its line of,top quality supplements., Glyc,n ... Glycine,Propionyl-L-Carnitine (GPLC) supplement, and the effects that it has ... athletes and trainers,around the globe., In clinical trials, ...
... Inc., presented,yesterday the anatomic effects of the ... lesions in an analysis at the,American Society ... The,12-month data presented by David Brown, MD, ... anatomic improvements on both,angiography and ocular coherence ...
... of www.AtlantaJobs.com . AtlantaJobs.com is the newest online job ... Atlanta area. , ... Atlanta, GA (PRWEB) October 13, ... the official launch of AtlantaJobs.com is the newest online ...
... 13, 2008 Five neonatology fellows have been ... in the area of follow-up care of the ... The grants, which underscore MedImmune,s commitment to expanding ... institution a $35,000 grant, totaling $175,000 in research ...
Other Medicine News:Health News:American Red Cross Offering Free Class to Help Military Families Cope With the Stress of Deployments 2Health News:Frost & Sullivan Awards Infor-Med for its Electronic Medical Record Technology 2Health News:Frost & Sullivan Awards Infor-Med for its Electronic Medical Record Technology 3Health News:NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting 2Health News:NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting 3Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2Health News:MedImmune grants 5 new fellowships to help expand premature infant follow-up care research 2
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
... A product you can trust ... practice: perform retinal, cataract, and glaucoma ... YAG III Combi is the optimal ... trabeculoplasty, and combined iridotomy. The push ...
... hospital-grade Holter Monitoring System, equipped with the ... analysis algorithm, Heart Rate Variability analysis and ... an Epicardia System in place have complete ... suit their needs, and managing their data. ...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
Medicine Products: